RHOKIINSA

This brand name is authorized in Austria, Croatia, Estonia, Ireland, Italy, Lithuania, Poland.

Active ingredients

The drug RHOKIINSA contains one active pharmaceutical ingredient (API):

1	Netarsudil UNII VL756B1K0U - NETARSUDIL MESYLATE
	Netarsudil, a Rho kinase inhibitor, is believed to reduce intraocular pressure (IOP) by increasing outflow of aqueous humor. Studies in animal and man suggest that the main mechanism of action is increased trabecular outflow. These studies also suggest that netarsudil lowers IOP by reducing episcleral venous pressure.
	Read more about Netarsudil

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
RHOKIINSA Eye drops, solution	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01EX05		S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EX Other antiglaucoma preparations
Discover more medicines within S01EX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1807152
IT	Agenzia del Farmaco	048362014
LT	Valstybinė vaistų kontrolės tarnyba	1088971
PL	Rejestru Produktów Leczniczych	100429757